Anavex Life Sciences Corp (AVXL)

[BIOChecker4]

I remember years ago when a lot of posters thought Australian regulators would be the easier path to approval of Blarcamesine. How did that work out? Fast forward to today and its European regulators who some believe will be easier on Anavex. Hence the opinion that “many companies are choosing to go for a Europe, the UK, etc. first.” Of course, no actual evidence of that has been offered.

IMO, the idea that Europe, the UK, etc. offer an easier path to approval versus the FDA is simply another excuse to let Missling off the hook.

As for all the negative views of the FDA, I guess these folks would be perfectly happy going back to the days of hucksters selling home-made concoctions off the back of horse-drawn wagons to frightened, desperate people. Me, I’m fine with the FDA for the most part. Is the agency perfect? No. Could it be more streamlined? Possibly, just like any other institution could be.